X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
hematology (18) 18
index medicus (18) 18
adult (13) 13
male (12) 12
middle aged (12) 12
female (11) 11
adolescent (8) 8
aged (8) 8
transplantation (8) 8
immunology (6) 6
treatment outcome (6) 6
child (5) 5
hematopoietic stem cells (5) 5
oncology (5) 5
paroxysmal nocturnal hemoglobinuria (5) 5
stem cells (5) 5
bone-marrow-transplantation (4) 4
medicine, research & experimental (4) 4
survival (4) 4
young adult (4) 4
aged, 80 and over (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
cancer (3) 3
chemotherapy (3) 3
child, preschool (3) 3
clinical symptoms (3) 3
cord blood stem cell transplantation (3) 3
disease-free survival (3) 3
follow-up studies (3) 3
genetics & heredity (3) 3
graft vs host disease - mortality (3) 3
graft vs host disease - prevention & control (3) 3
hematologic neoplasms - therapy (3) 3
hematology, oncology and palliative medicine (3) 3
hematopoietic stem cell transplantation (3) 3
hemic and lymphatic diseases (3) 3
incidence (3) 3
medicine, general & internal (3) 3
mortality (3) 3
prognosis (3) 3
recurrence (3) 3
retrospective studies (3) 3
review (3) 3
surgery (3) 3
transplantation, homologous (3) 3
acute disease (2) 2
acute lymphoblastic-leukemia (2) 2
analysis (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized (2) 2
antiphospholipid syndrome (2) 2
biochemistry & molecular biology (2) 2
brazil (2) 2
care and treatment (2) 2
cerebral venous thrombosis (2) 2
chronic lymphatic leukemia (2) 2
chronic lymphocytic leukemia (2) 2
complement inhibitor eculizumab (2) 2
criteria (2) 2
diagnosis (2) 2
graft vs host disease - drug therapy (2) 2
graft vs host disease - etiology (2) 2
graft vs host disease - immunology (2) 2
graft-versus-host disease (2) 2
graft-versus-host reaction (2) 2
guidelines (2) 2
health aspects (2) 2
hematologic neoplasms - mortality (2) 2
hematopoietic stem cell transplantation - adverse effects (2) 2
hepatitis b virus (2) 2
hepatitis c virus (2) 2
hodgkin disease (2) 2
immunohistochemistry (2) 2
immunosuppression (2) 2
immunosuppressive agents - therapeutic use (2) 2
immunotherapy (2) 2
in-vivo (2) 2
leukemia, lymphocytic, chronic, b-cell - genetics (2) 2
lymphatic leukemia (2) 2
lymphomas (2) 2
management (2) 2
medicine (2) 2
medicine & public health (2) 2
mutation (2) 2
natural-history (2) 2
neurosciences (2) 2
non-hodgkins-lymphoma (2) 2
nonrelapse mortality (2) 2
p53 genes (2) 2
proliferating cell nuclear antigen (2) 2
proteins (2) 2
proto-oncogene proteins c-mdm2 (2) 2
psychiatry (2) 2
relapse (2) 2
remission induction - methods (2) 2
risk factors (2) 2
salvage therapy - methods (2) 2
survival analysis (2) 2
survival rate (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Mycoses, ISSN 0933-7407, 05/2019, Volume 62, Issue 5, pp. 413 - 417
Journal Article
Haematologica, ISSN 0390-6078, 02/2014, Volume 99, Issue 2, pp. 370 - 377
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 04/2010, Volume 95, Issue 4, pp. 574 - 581
Journal Article
Journal Article
Journal Article
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, ISSN 2212-4403, 08/2017, Volume 124, Issue 2, pp. e85 - e85
Journal Article
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, ISSN 2212-4403, 2016, Volume 123, Issue 2, pp. e50 - e50
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017
Highlights • HaploSCT is a valuable alternative for HL patients relapsing after an ASCT. • In this series, 2-year PFS and OS probabilities were 54% and 66%,... 
Hematology, Oncology and Palliative Medicine
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4755 - 4755
Introduction: The prompt initiation of a betalactam antibiotic in febrile neutropenia (FN) is standard of care in patients with hematologic malignancies and... 
Journal Article
20.